CD8A and neoplasm: Depletion efficiency of CD8+ T cells was confirmed by flow cytometry for the spleen, blood and tumor of the mice (online supplemental figure S2J) and by IHC staining for CD8+ in the tumors on day 30 (online supplemental figure S2K).